MET and glioblastoma: The autocrine HGF-Met dependence of U87 MG is consistent with Met as a functional marker of a glioblastoma stem cell phenotype [21] and the well-documented frequency of functional HGF-Met signaling in GBM [14,15,16,17,18,19,20,21,22,23,24,25].